| |
| |
|
| Insider
Information: |
Glenn Gregory M |
| Relationship: |
President, R&D |
| City: |
Gaithersburg |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
18,339 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,593 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
18,339 |
|
|
| Total
Value |
$6,593 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -200.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novavax Inc |
NVAX |
President, R&D |
2023-03-10 |
18,339 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
128 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-09-27 |
4 |
D |
$231.04 |
$8,317 |
D/D |
(36) |
5,402 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, Research and Development |
• – – |
2014-01-31 |
4 |
B |
$2.29 |
$9,394 |
D/D |
4,102 |
31,000 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, Research and Development |
• – – |
2016-01-31 |
4 |
B |
$4.38 |
$10,376 |
D/D |
2,369 |
2,427 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2018-01-31 |
4 |
B |
$0.88 |
$11,250 |
D/D |
12,784 |
27,211 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2017-11-09 |
4 |
B |
$1.13 |
$11,300 |
D/D |
10,000 |
14,427 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2018-07-31 |
4 |
B |
$0.88 |
$11,446 |
D/D |
13,007 |
60,218 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2019-01-31 |
4 |
B |
$0.88 |
$11,588 |
D/D |
13,168 |
73,386 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2019-09-08 |
4 |
D |
$5.50 |
$13,937 |
D/D |
(2,534) |
9,743 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2023-03-07 |
4 |
B |
$7.04 |
$14,088 |
D/D |
2,000 |
13,473 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2023-03-10 |
4 |
D |
$6.52 |
$15,857 |
D/D |
(2,432) |
18,339 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-08-26 |
4 |
D |
$230.34 |
$16,584 |
D/D |
(72) |
6,743 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2022-12-14 |
4 |
D |
$17.23 |
$17,799 |
D/D |
(1,033) |
8,009 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-09-27 |
4 |
OE |
$5.95 |
$20,587 |
D/D |
3,460 |
5,438 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-11-26 |
4 |
OE |
$5.95 |
$20,587 |
D/D |
3,460 |
5,438 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2023-03-06 |
4 |
B |
$7.48 |
$22,454 |
D/D |
3,000 |
11,473 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-04-15 |
4 |
D |
$202.09 |
$28,697 |
D/D |
(142) |
7,488 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-03-15 |
4 |
D |
$217.46 |
$28,705 |
D/D |
(132) |
7,498 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-05-17 |
4 |
D |
$140.16 |
$28,733 |
D/D |
(205) |
7,425 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-06-15 |
4 |
D |
$187.07 |
$28,809 |
D/D |
(154) |
7,476 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-07-15 |
4 |
D |
$179.14 |
$28,842 |
D/D |
(161) |
7,473 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-02-16 |
4 |
D |
$262.70 |
$28,897 |
D/D |
(110) |
7,520 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, Research and Development |
• – – |
2014-07-31 |
4 |
B |
$2.28 |
$28,972 |
D/D |
12,707 |
16,809 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, Research and Development |
• – – |
2015-08-18 |
4 |
OE |
$2.11 |
$31,650 |
D/D |
15,000 |
16,158 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2018-05-14 |
4 |
B |
$1.64 |
$32,800 |
D/D |
20,000 |
47,211 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
Chief Scientific Officer |
• – – |
2012-05-10 |
4 |
B |
$1.35 |
$33,750 |
D/D |
25,000 |
29,000 |
2.74 |
- |
|
128 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
